Brief: Tcr² Therapeutics Reports Q1 2020 Financial Results

TCR2 Therapeutics

14/05/2020 11:51

May 14 (Reuters) - TCR2 Therapeutics Inc  TCRR.O :
    * TCR² THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * QTRLY LOSS PER SHARE $0.65
    * ENDED Q1 OF 2020 WITH $140.7 MILLION IN CASH, CASH
EQUIVALENTS,
AND INVESTMENTS
    * PROJECTS NET CASH USE OF $60-70 MILLION FOR 2020
    * UPDATING OUR TC-210 GUIDANCE TO EXPECT AN INTERIM UPDATE
FROM
PHASE 1 PORTION IN MID-2020
    * Q1 EARNINGS PER SHARE VIEW $-0.61 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9wdHdy 
Further company coverage:  TCRR.O 

 ((Reuters.Briefs@thomsonreuters.com;))